|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/30 | |||
| A61K 31/19 | |||
| A61P 25/14 | |||
| A61P 25/26 |
| (11) | Number of the document | 2341910 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09825191.1 |
| Date of filing the European patent application | 2009-10-20 | |
| (97) | Date of publication of the European application | 2011-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/061312 |
| Date | 2009-10-20 |
| (87) | Number | WO 2010/053691 |
| Date | 2010-05-14 |
| (30) | Number | Date | Country code |
| 264709 | 2008-11-04 | US |
| (72) |
ROURKE, Andrea, US
ALLPHIN, Clark, US
MURPHY, Maura, US
|
| (73) |
Jazz Pharmaceuticals, Inc.,
3170 Porter Drive, Palo Alto, CA 94304,
US
|
| (54) | IMMEDIATE RELEASE DOSAGE FORMS OF SODIUM OXYBATE |
| IMMEDIATE RELEASE DOSAGE FORMS OF SODIUM OXYBATE |